Skip to main content
44°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dexcom Inc
(NQ:
DXCM
)
128.37
+1.72 (+1.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dexcom Inc
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Xylem, DexCom And 2 Other Stocks Insiders Are Selling
February 22, 2024
The Nasdaq 100 closed lower by around 0.4% on Wednesday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
Here's How Much $100 Invested In DexCom 15 Years Ago Would Be Worth Today
February 21, 2024
Via
Benzinga
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
February 14, 2024
Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive.
Via
InvestorPlace
These 2 Growth Stocks Could Soar 33% and 45% According to Wall Street Analysts. Are They Smart Buys Now?
February 13, 2024
Expectations are high for companies making blood sugar monitors and business automation software.
Via
The Motley Fool
Wall Street's Next Stock-Split Stocks Are Liable to Be Familiar Names
February 12, 2024
Nine high-profile stocks -- Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk -- have split since mid-2021. Two of these companies appear ready...
Via
The Motley Fool
DexCom: Q4 Earnings Insights
February 08, 2024
Via
Benzinga
Prediction: 2 Stocks That Could Trounce the Market
February 08, 2024
They have done it before.
Via
The Motley Fool
Earnings Scheduled For February 8, 2024
February 08, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
Via
Benzinga
2 No-Brainer Healthcare Stocks to Buy Right Now
February 10, 2024
Companies in the healthcare industry tend to generate returns in a wide range of market environments.
Via
The Motley Fool
Continuous Glucose Monitor Maker Dexcom's Q4 Profit Triples On Volume Growth And New Customer Additions
February 09, 2024
Dexcom's Q4 2023 performance, reporting $1.03 billion sales, $256.3 million profits, and beating estimates. Dexcom projects $4.15-$4.35 billion in 2024 revenues. William Blair affirms Outperform...
Via
Benzinga
DexCom (DXCM) Q4 2023 Earnings Call Transcript
February 08, 2024
DXCM earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
If You Invested $100 In This Stock 15 Years Ago, You Would Have $13,000 Today
February 07, 2024
Via
Benzinga
2 Phenomenal Stocks to Buy for the New Year
February 03, 2024
These growth stocks are raking in profits and cash as leaders in their respective industries.
Via
The Motley Fool
Stryker Stock Sees Relative Strength Rating Jump To 84
February 01, 2024
The Relative Strength (RS) Rating for Stryker stock jumped into a new percentile Thursday, with a rise from 76 to 84.
Via
Investor's Business Daily
NASDAQ:DXCM: a strong growth stock preparing for the next leg up?.
January 25, 2024
DEXCOM INC (NASDAQ:DXCM)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
Via
Chartmill
Evaluating NASDAQ:DXCM for Growth Investment Opportunities.
January 25, 2024
Why the growth investor may take a look at NASDAQ:DXCM.
Via
Chartmill
Expert Ratings For DexCom
January 23, 2024
Via
Benzinga
These 2 Growth Stocks Are Brilliant Buys for the New Year
January 23, 2024
Business is booming for these stocks, and investors might want to stop and take note.
Via
The Motley Fool
Don't overlook NASDAQ:DXCM—a stock with solid growth prospects and a reasonable valuation.
January 23, 2024
Investors should take note ofDEXCOM INC (NASDAQ:DXCM), a growth stock that remains attractively priced.
Via
Chartmill
3 Mid-Cap Stocks Poised for a Breakout in 2024
January 16, 2024
Mid-cap stocks are expected to have a breakout year especially in light of their underperformance in 2023 with these equities looking strong.
Via
InvestorPlace
The 3 Best Growth Stocks to Buy in January 2024
January 14, 2024
The best growth stocks to buy for 2024 with an impressive growth history and solid long-term tailwinds to support 30% EPS growth.
Via
InvestorPlace
Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review
January 12, 2024
The major indexes and leading stocks rebounded. Bitcoin ETFs fell in their debut.
Via
Investor's Business Daily
Topics
ETFs
Here's How Much $1000 Invested In DexCom 15 Years Ago Would Be Worth Today
January 10, 2024
Via
Benzinga
A Closer Look at DexCom's Options Market Dynamics
January 08, 2024
Via
Benzinga
2 Growth Stocks That Could Make You Richer in 2024 and Beyond
January 09, 2024
Last year wasn't great for either stock, but that's no reason to ignore them.
Via
The Motley Fool
History Says the Nasdaq Will Soar in 2024: 1 Stock-Split AI Growth Stock to Buy Now and Hold Forever
January 09, 2024
Nvidia is well positioned to create value for patient shareholders, given its leadership in artificial intelligence chips.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Stocks to Capitalize on the Telehealth Explosion
January 08, 2024
These three telehealth stocks are leading the way for improved telehealth offerings, highlighted after the pandemic.
Via
InvestorPlace
Dexcom's Recent 66% Run Continues With A Breakout On Bullish Fourth-Quarter Sales
January 08, 2024
Dexcom beat fourth-quarter sales expectations and issued stronger-than-usual annual guidance.
Via
Investor's Business Daily
Is NASDAQ:DXCM a Fit for Growth Investing Strategies?
January 04, 2024
Should you consider DEXCOM INC (NASDAQ:DXCM) for growth investing?
Via
Chartmill
The Latest Analyst Ratings For DexCom
January 03, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
19
20
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.